As the market for medical products comes under pressure as a result of the COVID-19 crisis, the European Union Intellectual Property Office (EUIPO) published a report on Monday 23 March showing that counterfeit medicines represents a major global scourge.
In 2016, the total value of counterfeit products marketed worldwide reached 4.03 billion euros. The loss of revenue for the EU is estimated at around 1.7 billion euros.
The report, published in conjunction with the Organisation for...